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Abstract
To further investigate the genetic diversity of hepatitis B virus (HBV) genotype A in Africa, we analysed 263 HBV strains from Nigeria
(n = 163) and Cameroon (n = 100). Phylogenetic analysis of S fragment sequences attributed 175 strains (66.5%) to genotype E and 88
(33.5%) to genotype A. In Cameroon, genotype A strains were the most prevalent (79/100, 79.0%), whereas, in Nigeria, genotype E
was highly dominant (154/163, 94.5%). The genotype A strains grouped with reference strains of subgenotype A3 (n = 8), the provi-
sional subgenotype A5 (n = 43), a recently reported new variant from Rwanda (n = 35), or as outliers (n = 2). Ten complete genome
sequences obtained from strains that clustered with the new variant from Rwanda formed a separate group supported by a bootstrap
value of 96. The between-group distance to other potential or recognized subgenotypes of genotype A was at least 3.81%. Thus, the
new group of strains could be considered as a new subgenotype of HBV genotype A, tentatively named ‘A7’. Interestingly, the ‘A7’
strains from Rwanda and Cameroon showed an interspersed clustering, but essentially no other (sub)genotypes were shared between
the two countries, suggesting that ‘A7’ may have evolved in a yet unknown place and may have only relatively recently spread to
Rwanda and Western Cameroon. Strains attributed to provisional subgenotype A5 were found for the ﬁrst time in Cameroon (n = 36)
and Central Nigeria (n = 2), indicating that A5 is more widespread than previously thought.
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Introduction
An estimated two billion people worldwide have been
infected by hepatitis B virus (HBV) at some point during
their lives and, as a result, more than 350 million people
are chronic carriers of the virus. Every year, approximately
one million deaths are caused by chronic HBV infection.
Thus, despite effective vaccines, HBV remains a major public
health problem worldwide [1]. In many countries, particu-
larly in sub-Saharan Africa, HBV is hyperendemic with a
hepatitis B surface antigen seroprevalence above 8% [2].
HBV genotypes have been deﬁned based on a genetic dis-
tance of 8% or more between complete genome sequences
or 4% between S gene sequences [3,4]. Currently, eight
genotypes (A–H) of HBV are recognized and two new
genotypes have recently been proposed: I [5,6] and J [7].
Some genotypes appear to show differences in response to
certain anti-viral treatment regimens (e.g. with interferon)
[8,9] and in clinical outcome [10–12]. Most of the genotypes
have a distinct geographic distribution [13–17]. Genotype D
is the dominant genetic variant in the North of Africa [2].
In sub-Saharan Africa, genotype E predominates in the
‘genotype E crescent’, which spans from Senegal to Namibia
in the South and to the Central African Republic in the East
[2,17–19]. Genotype A appears to be the most prevalent
genotype in the South and East of the continent [2] and
was also relatively frequent in Cameroon [15,17,19]. Six
subgenotypes have so far been proposed for genotype A.
A1 is found in southern and eastern regions of Africa, but
also in Asia and America [20–24]. A2 is mostly reported
from Europe, but has also been detected in Africa, especially
South Africa [14,25]. A3 was mainly found in West African
countries, such as Cameroon and Gabon [13,16,19].
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Of both A4 and potential subgenotype A5, only a few
strains were found in sub-Saharan Africa. While A4 (n = 3)
was reported from Mali and the Gambia [13,17], A5 strains
(n = 3) were initially only reported from the Southwest of
Nigeria [17], a region that belonged to the former ‘slave
coast’. Recently, a surprisingly high prevalence of subgeno-
type A5 was found in African descendants in Haiti [20], sug-
gesting that this variant must have been common at least in
the part of Africa where the slaves were captured before
being shipped across the Atlantic. The recently proposed
A6 subgenotype includes three strains from African–Belgian
patients originating from Congo and Rwanda [26]. In addi-
tion to these previously suggested subgenotypes, S fragment
sequences of a new variant of HBV genotype A were
recently reported from Rwanda [21], indicating that the
diversity of this genotype is still not fully understood. To
further investigate the genetic diversity of genotype A, we
intensiﬁed our genotype surveillance in the former ‘slave
coast’ region of Nigeria, the only country in Africa where
A5 has been found so far, and in Cameroon, the West Afri-
can country with the highest prevalence of genotype A
infections.
Materials and methods
Samples
Serum samples from three different cohorts from Nigeria
(25xxx: Lagos, 1995 and 2003; 29xxx: Ibadan, 2005; 36xxx:
Abuja/Kefﬁ, 2005–2006) and another three from Bamenda in
Cameroon (34xxx: 2005; 41xxx and 42xxx: 2006–2007)
were included in the present study.
DNA extraction and PCR ampliﬁcation
DNA was extracted using the QIAamp DNA Blood Mini Kit
(Qiagen, Venlo, The Netherlands) in accordance with the
manufacturer’s protocol. Ampliﬁcation of the S fragment,
which includes the entire S gene, and of the complete gen-
ome of HBV, was performed by semi-nested PCRs as
described previously [17].
Sequencing and phylogenetic analysis
Nested PCR products were puriﬁed and sequenced as
described previously [17]. S fragment sequences with more
than ﬁve and complete genomes with more than 20 ambig-
uous nucleotides were considered as potentially mixed-
infected and were excluded from the analysis. Phylogenetic
analysis was performed using MEGA 4 software [27] with
the Neighbour-joining and Kimura two-parameter methods.
Only bootstrap values of 70 or above (1000 replications)
are shown in the phylogenetic trees. Full genome
sequences were also analysed by the maximum parsimony
method. Genetic distances were calculated with MEGA
using pairwise, overall mean, and within- and between-
group mean comparisons. More than 300 complete genome
sequences of HBV genotype A available on GenBank (July
2009), from Haiti [20], from African–Belgian patients [26]
and from the present study were included in the calcula-
tions. Unique S fragment and complete genome sequences
obtained during the present study were submitted to Gen-
Bank under accession numbers FN547153–FN547364 and
FN545821–FN545842, respectively. BootScan analyses were
performed using SIMPLOT, version 3.5.1 [28] with the
default settings.
Results
Analysis of the S fragment sequences
Phylogenetic analysis of 815 nucleotides of the S fragment of
263 strains attributed 175 strains (66.5%) to genotype E
(Fig. 1a) and 88 (33.5%) to genotype A (Fig. 1b). In Camer-
oon, genotype A strains were the most prevalent (79/100,
79.0%), whereas, in Nigeria, genotype E was highly dominant
(154/163, 94.5%). Except for two outliers (34010, 42211),
which could not be attributed to any genotype A subgeno-
type, the genotype A strains grouped with reference strains
of subgenotype A3 (n = 8), the provisional subgenotype A5
(n = 43) or with the recently reported new variant from
Rwanda (n = 35) [21] (Fig. 1b). While in Nigeria, only A3
(n = 2) and A5 strains (n = 7) were detected, the two out-
liers, A3 (n = 6), A5 (n = 36) and new variant strains
(n = 35) were found in Cameroon.
The genotype E strains showed an overall mean genetic
distance of 0.96% (maximum 3.65% between 36282 and
36311), with the diversity among strains from Nigeria being
slightly higher than among those from Cameroon (0.98% vs.
0.65%). The opposite was observed for the genotype A
strains: the mean genetic distance was higher among the
strains from Cameroon (1.69%) than among the ones from
Nigeria (1.36%). The overall mean for all 88 genotype A
strains was 1.70% (maximum 4.93% between 34010 and
34036). The 47 strains in total (12 from Rwanda and 35
from Cameroon) belonging to the new variant of genotype
A showed an overall genetic distance of 1.53% (maximum
4.31% between 34036 and 42226), which was slightly higher
than that for sequences from Cameroon only (1.50%).
Twenty-six of the 47 strains (55.32%) were of serotype
ayw1, 19 (40.43%) of type adw2 and two strains (4.26%,
34036, 42064) were identiﬁed as ay only.
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FIG. 1. Genotype E (a) and A cluster (b) of a phylogenetic tree based on 815 nucleotides of the S fragment of sequences obtained during the
present study as well as reference sequences of genotypes A–J (Neighbour-joining algorithm using the Kimura two-parameter model). Symbols
designate the country of origin for strains: Nigeria (•), Cameroon ( ) and Rwanda (¤). Only single strains of sequences from the same cohort
with identical clustering are shown (18, 9, 5, 4 and 3 strains grouped similar to 42126, 25004, 42002, 25135 and 42334, respectively; two strains
each grouped identical to 25060, 36048 and 42203; one strain each identical to 36135, 36083, 29070, 29085, 36062, 25044 and 49037). In (a),
clusters containing only sequences from Nigeria are represented by triangles; clusters containing both sequences from Cameroon and Nigeria
are shown in full detail.
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Complete genome analysis
Complete genome sequences were obtained for 45 of the
263 strains investigated in the present study. Analysis of
these complete genome sequences assigned seven to geno-
type E (four from Nigeria, three from Cameroon) and 38 to
genotype A (one from Nigeria, 37 from Cameroon) (Fig. 2).
While the genotype E strains were interspersed with previ-
ously reported West African genotype E strains, the geno-
type A strains grouped with reference sequences of A3
(n = 2, including the strain from Nigeria), provisional sub-
genotype A5 (n = 25) or separately from all known genotype
A subgenotypes (n = 10). The separate clustering of the lat-
ter sequences was also conﬁrmed by maximum parsimony
analysis (data not shown). The ten sequences correspond to
strains that in the S fragment analysis clustered with the
sequences of the new variant from Rwanda [21]. Strain
34010 could not be clearly assigned to any subgenotype, but
clustered as an outlier to the group formed by subgenotypes
A3, A4, A5 and the new variant (Fig. 2).
Among the genotype E strains, the overall mean genetic
distance was 1.66% compared to 2.17% among the genotype
A strains. The within-group mean distance for the ten new
variant genotype A sequences was 2.29%, with the two most
closely-related strains (42063, 42064) differing by 0.63% and
the two most distant strains (42064, 42145) by 3.97%. The
between-group distance of the new variant to the other rec-
ognized and potential subgenotypes of genotype A was low-
est to the A5 cluster with 3.81%. Compared to groups
formed by representative sequences of genotypes B–J, it was
at least 8.46% (Table 1).
BLAST searches of the complete genome sequences of
the ten new variant strains showed that they were most clo-
sely related to a strain from Haiti (FJ692601, 95–96% maxi-
mal identity). In addition, BootScan analysis for all the
sequences showed mostly similarities to other genotype A
sequences, mainly to subgenotype A3, A4 and A6 strains,
but, in the majority of cases, the percentage of permuted
trees stayed below 90 (data not shown). Phylogenetic
analysis of the new variant strains together with reference
sequences of genotypes A–J based on the S gene (Fig. 3a),
the preC/C (Fig. 3b) and the preS (Fig. 3c) regions of the
HBV genome did not show evidence of recombination.
Discussion
In the present study, we describe 35 strains of HBV, which,
together with 12 strains reported from Rwanda [21],
represent a new variant of genotype A. BLAST analysis of
TABLE 1. Between-group mean ± SD genetic distances (in %) between the ‘A7’ strains and other genotype A subgenotypes
(above) and representative strains of genotypes B–J (below) calculated using MEGA, version 4
A1 A2 A3 A4 A5 A6
A7 5.10 ± 0.37 5.34 ± 0.33 4.24 ± 0.24 3.99 ± 0.25 3.81 ± 0.24 5.10 ± 0.35
B C D E F G H I J
A7 10.46 ± 0.50 9.82 ± 0.42 10.91 ± 0.52 10.88 ± 0.56 15.77 ± 0.71 12.24 ± 0.65 16.00 ± 0.79 8.46 ± 0.46 12.54 ± 0.60
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FIG. 2. Phylogenetic tree based on complete genome sequences
(Neighbour-joining algorithm using the Kimura two-parameter
model). Symbols designate the country of origin for strains: Nigeria
(•) and Cameroon ( ). Seventeen and six strains from the same
cohorts grouping as strains 42128 and 42002, respectively, are not
shown.
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ten complete genome sequences demonstrated that these
strains were most closely related (95–96% maximal identity)
to a subgenotype A5 strain from Haiti (FJ692601). Recently,
it was suggested that HBV strains could be separated into
subgenotypes based on a nucleotide divergence of approxi-
mately 4% over the complete genome and a good bootstrap
support [29]. In the same study, the previously suggested
subgenotype A4 [17] was reported to show inter-subgeno-
type divergences of at least 3.76 ± 0.32%, which was consid-
ered to fall within the range delineating subgenotypes [29].
Thus, the new group described in this study could also be
considered as a new subgenotype of genotype A because it
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FIG. 3. Phylogenetic trees based on the S gene (a), the preC/C region (b) and the preS region (c) of the hepatitis B virus genome (Neighbour-
joining algorithm using the Kimura two-parameter model). Symbols designate the new variant strains ( ).
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has high bootstrap support of 96 (Fig. 2) and shows a genetic
distance of at least 3.81 ± 0.24% to other subgenotypes
(Table 1). Following the designation for previously identiﬁed
new subgenotypes of HBV genotype A [17], the new strains
reported in the present study are tentatively referred to as
‘A7’ strains.
Interestingly, the ‘A7’ strains have so far only been found in
Rwanda and now in Western Cameroon. The interspersing of
strains from Rwanda with those from Cameroon in the
phylogenetic tree and the absence of geographical clusters
suggest a recent or even ongoing strain exchange between
both countries. However, no subgenotype A1 or genotype D
strains, which were both common in Rwanda (35.56% and
22.22% of strains), have so far been found in Cameroon, and
no genotype E, and only single A3 and A5 strains, all present
in Cameroon, have been detected in Rwanda [21]. Thus,
essentially only subgenotype ‘A7’ was shared between both
countries. The absence of ‘A7’ strains in Haiti [20] and in the
Americas suggests that, in contrast to A5, this subgenotype
was not very common when and where the slaves were
rounded up for the transatlantic slave trade. It is also notewor-
thy that ‘A7’, despite its high prevalence at least in the
Western part of Cameroon (Bamenda), where the samples for
the present study were collected, escaped detection in earlier
studies conducted throughout the country [15,17,19]. One
explanation that may reconcile these partly contradictory
ﬁndings would be an evolution of ‘A7’ in a yet to be identiﬁed
region or country, from where it may have spread recently to
only certain cohorts and/or geographical regions in both
Rwanda and Cameroon.
Before the present study was conducted, A5 strains
(n = 3) were only found in one location in Africa, namely in
Southwest Nigeria [17]. Now, we have found subgenotype
A5 strains also in Cameroon (n = 36) and in Abuja in Cen-
tral Nigeria (n = 2), indicating that the supposedly very rare
subgenotype A5 is (and possibly was) more widespread than
previously thought. This may also explain why 20% of the
HBV strains found in African descendants in Haiti belonged
to this subgenotype [20]. Despite its high prevalence in Cam-
eroon, the genetic diversity among the A5 strains was quite
low (0.30% on the S fragment), with many very similar or
identical sequences. Unless there was a sampling bias, this
observation suggests that subgenotype A5 was only recently
introduced into Western Cameroon possibly from neigh-
bouring Nigeria. A recent introduction combined with a lim-
ited geographical spread may also explain why A5 was not
detected in earlier studies conducted in Cameroon
[15,17,19].
In Nigeria, genotype E is clearly predominant, as we
reported in our earlier studies [17,19,30]. The few genotype
A strains were attributed to subgenotype A3 and provisional
subgenotype A5, which was detected for the ﬁrst time in
Central Nigeria. Not a single subgenotype ‘A7’ strain was found
in Nigeria, despite the proximity to neighbouring Cameroon.
Cameroon, on the other hand, is exceptional in this
region of Africa because it has a high prevalence of genotype
A [15,17,19]. In the present study, almost 80% of the strains
belonged to genotype A (subgenotypes 3 (n = 6), 5 (n = 36)
and 7 (n = 35)). It remains unclear why Cameroon is so
different from the other West African countries where
genotype E is largely predominant [2,17,19,30], especially
since the high genotype A prevalence does not seem to be
restricted to certain cohorts or geographical regions
[15,17,19]. The high genetic diversity of genotype A in Africa
and the presence of all subgenotypes and variants (A3, A4
and A7 have been found so far exclusively on this continent)
further supports an African origin of genotype A [13]. Fur-
ther large-scale studies like the one described here are, how-
ever, needed to obtain a full understanding of the genotype
distribution and diversity in Africa.
In conclusion, we presented the ﬁrst complete genome
sequences of a previously described new variant of HBV
genotype A [21]. This group of sequences was supported by a
high bootstrap value and was clearly distinct from other HBV
subgenotypes, thus warranting the status of a new subgeno-
type (‘A7’) of HBV. Amongst the different (sub)genotypes
found in Cameroon (A3, A5, A7, E) and Rwanda (A1, A3, A5,
A7, B4, C2, D3, D4) [21], essentially only ‘A7’ is shared by,
and so far exclusively found in, both countries. The absence of
‘A7’ in the slave destination countries and in previously studied
cohorts in Cameroon, together with the interspersed cluster-
ing of strains from Cameroon and Rwanda, suggests a rather
recent introduction into Cameroon, probably combined with
a very restricted distribution in the Western part of the
country. While a genetically rather homogeneous genotype E
dominates in Nigeria, an increasingly heterogeneous genotype
A unfolds in neighbouring Cameroon.
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